norgestimate has been researched along with norethindrone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, S; Stanczyk, FZ | 1 |
| Casper, RF; Chachra, D; Grynpas, MD; Kasra, M; MacLusky, NJ; Vanin, CM | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Charkoudian, N; Johnson, JM | 1 |
| Godwin, A; Lippman, J; Massaro, J; Siu, C; Sulak, P | 1 |
| Caubel, P; Lim, P; Ylikorkala, O | 1 |
| Caubel, P; Lim, PC; Rozenberg, S | 1 |
| Caubel, P; Lane, R; Wahlström, T; Ylikorkala, O | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF | 1 |
| Buono, MJ; Martin, JG | 1 |
| Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
| Hall, KS; Trussell, J | 1 |
| Chang, W; Dragoo, JL; Hsue, L; Konopka, JA; Thio, T | 1 |
| Chiu, YL; Feldman, RA; Klein, CE; Ng, J | 1 |
1 review(s) available for norgestimate and norethindrone
| Article | Year |
|---|---|
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
9 trial(s) available for norgestimate and norethindrone
| Article | Year |
|---|---|
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Topics: Androgens; Contraception; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Menstrual Cycle; Norethindrone; Norethindrone Acetate; Norgestrel; Patient Satisfaction | 1999 |
Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Triglycerides | 2000 |
Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Topics: Adult; Aged; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progestins; Uterine Hemorrhage; Vasomotor System | 2001 |
Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Topics: Adult; Aged; Biopsy; Cholesterol; Drug Administration Schedule; Endometrium; Estradiol; Female; Hormone Replacement Therapy; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norgestrel; Uterine Hemorrhage | 2002 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome | 2008 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |
6 other study(ies) available for norgestimate and norethindrone
| Article | Year |
|---|---|
Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate.
Topics: Absorptiometry, Photon; Animals; Bone Density; Dihydrotestosterone; Drug Implants; Estradiol; Female; Lumbar Vertebrae; Norethindrone; Norgestrel; Ovariectomy; Rats; Rats, Sprague-Dawley; Silicone Elastomers | 1995 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclooxygenase Inhibitors; Drug Combinations; Estradiol Congeners; Female; Heart Rate; Hot Temperature; Humans; Ibuprofen; Mestranol; Norethindrone; Norgestrel; Prostaglandins; Reflex; Skin; Stress, Physiological; Sweating; Vasodilation | 1999 |
Types of combined oral contraceptives used by US women.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Estradiol Congeners; Family Characteristics; Female; Health Surveys; Humans; Norethindrone; Norgestrel; Progesterone Congeners; United States; Young Adult | 2012 |
The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
Topics: Androstenes; Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Norethindrone; Norgestrel; Progestins; Rats; Rats, Sprague-Dawley | 2020 |
Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women.
Topics: Female; Follicle Stimulating Hormone; Humans; Hydrocarbons, Fluorinated; Luteinizing Hormone; Norethindrone; Norgestrel; Pyrimidines | 2021 |